Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VXRT | Common Stock | Options Exercise | $5.65K | +18.2K | $0.31 | 18.2K | Jun 11, 2021 | Direct | ||
transaction | VXRT | Common Stock | Sale | -$86.1K | -10K | -54.82% | $8.61* | 8.24K | Jun 11, 2021 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VXRT | Stock Option (right to buy) | Options Exercise | $0 | -18.2K | -33.33% | $0.00 | 36.5K | Jun 11, 2021 | Common stock | 18.2K | $0.31 | Direct | F1 |
Id | Content |
---|---|
F1 | The shares subject to this option shall vest annually over three years from the vesting commencement date of October 25, 2019, the date of the grantee's appointment as a director of Vaxart, Inc. |